Transcriptional analysis of protective antigen-stimulated PBMC from non-human primates vaccinated with the anthrax vaccine absorbed

Vaccine

Volumn 24, Issue 17, 2006, Pages 3609-3617

  Rogers, James V ^a   Casbohm, Stacy L ^a   Giannunzio, Lenore F ^a   Sinnott, Loraine T ^a   Rust, Steven W ^a   Brys, April M ^a   Durnford, Joyce M ^a   Quinn, Conrad P ^b   Robinson, David M ^a   Hunt, Robert E ^a   Estep, James E ^a   Sabourin, Carol L K ^a  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Anthrax; Non human primate; Protective antigen; Vaccine

Indexed keywords

ANTHRAX VACCINE; ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; GENETIC TRANSCRIPTION; MONKEY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTHRAX VACCINES; ANTIGENS, BACTERIAL; ANTIGENS, CD; BACTERIAL TOXINS; GENE EXPRESSION PROFILING; IMMUNITY, NATURAL; INTERFERONS; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTORS; VACCINATION; VACCINES, SYNTHETIC;

EID: 33645215610     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.056     Document Type: Article

References (63)

1. A. Agrawal, J. Lingappa, S.H. Leppla, S. Agrawal, A. Jabbar, and C. Quinn Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin Nature 424 2003 329 334
2. L. Baillie The development of new vaccines against Bacillus anthracis J Appl Microbiol 91 2001 609 613
3. R.L. During, W. Li, B. Hao, J.M. Koenig, D.S. Stephens, and C.P. Quinn Anthrax lethal toxin paralyzes neutrophil actin-based motility J Infect Dis 192 2005 837 845
4. A.J. Phipps, C. Premanandan, R.E. Barnewall, and M.D. Lairmore Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines Microbiol Mol Biol Rev 68 2004 617 629
5. D. Galloway, A. Liner, J. Legutki, A. Mateczun, R. Barnewall, and J. Estep Genetic immunization against anthrax Vaccine 22 2004 1604 1608
6. M.L. Gu, S.H. Leppla, and D.M. Klinman Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen Vaccine 17 1999 340 344
7. G. Hermanson, V. Whitlow, S. Parker, K. Tonsky, D. Rusalov, and M. Ferrari A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores Proc Natl Acad Sci USA 101 2004 13601 13606
8. B.W. McBride, A. Mogg, J.L. Telfer, M.S. Lever, J. Miller, and P.C. Turnbull Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers Vaccine 16 1998 810 817
9. B.M. Price, A.L. Liner, S. Park, S.H. Leppla, A. Mateczun, and D.R. Galloway Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein Infect Immun 69 2001 4509 4515
10. J. Riemenschneider, A. Garrison, J. Geisbert, P. Jahrling, M. Hevey, and D. Negley Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus Vaccine 21 2003 4071 4080
11. J.P. Barnard, and A.M. Friedlander Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen Infect Immun 67 1999 562 567
12. P.N. Boyaka, A. Tafaro, R. Fischer, S.H. Leppla, K. Fujihashi, and J.R. McGhee Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen J Immunol 170 2003 5636 5643
13. D.J. Chabot, A. Scorpio, S.A. Tobery, S.F. Little, S.L. Norris, and A.M. Friedlander Anthrax capsule vaccine protects against experimental infection Vaccine 23 2004 43 47
14. P.F. Fellows, M.K. Linscott, B.E. Ivins, M.L. Pitt, C.A. Rossi, and P.H. Gibbs Efficacy of a human anthrax vaccine in guinea piga, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographic origin Vaccine 19 2001 3241 3247
15. P.F. Fellows, M.K. Linscott, S.F. Little, P. Gibbs, and B.E. Ivins Anthrax vaccine efficacy in golden Syrian hamsters Vaccine 20 2002 1421 1424
16. H.C. Flick-Smith, E.L. Waters, N.J. Walker, J. Miller, A.J. Stagg, and M. Green Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain Microb Pathog 38 2005 33 40
17. B.E. Ivins, M.L. Pitt, P.F. Fellows, J.W. Farchaus, G.E. Benner, and D.M. Waag Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques Vaccine 16 1998 1141 1148
18. B.E. Ivins, P.F. Fellows, and G.O. Nelson Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs Vaccine 12 1994 872 874
19. B.E. Ivins, S.L. Welkos, S.F. Little, M.H. Crumrine, and G.O. Nelson Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants Infect Immun 60 1992 662 668
20. S.F. Little, B.E. Ivins, P.F. Fellows, M.L. Pitt, S.L. Norris, and G.P. Andrews Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine Vaccine 22 2004 422 430
21. H. Marcus, R. Danieli, E. Epstein, B. Velan, A. Shafferman, and S. Reuveny Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine Infect Immun 72 2004 3471 3477
22. M.L. Pitt, S.F. Little, B.E. Ivins, P. Fellows, J. Barth, and J. Hewetson In vitro correlate of immunity in a rabbit model of inhalational anthrax Vaccine 19 2001 4768 4773
23. S. Reuveny, M.D. White, Y.Y. Adar, Y. Kafri, Z. Altboum, and Y. Gozes Search for correlates of protective immunity conferred by anthrax vaccine Infect Immun 69 2001 2888 2893
24. S.L. Welkos, T.J. Keener, and P.H. Gibbs Differences in susceptibility of inbred mice to Bacillus anthracis Infect Immun 51 1968 795 800
25. D.N. Baldwin, V. Vanchinathan, P.O. Brown, and J.A. Theriot A gene-expression program reflecting the innate immune response of cultured intestinal epithelial cells to infection by Listeria monocytogenes Genome Biol 4 2004 R2
26. N.H. Bergman, K.D. Passalacqua, R. Gaspard, L.M. Shetron-Rama, J. Quackenbush, and P.C. Hanna Murine macrophage transcriptional responses to Bacillus anthracis infection and intoxication Infect Immun 73 2005 1069 1080
27. J.C. Boldrick, A.A. Alizadeh, M. Diehn, S. Dudoit, C.L. Liu, and C.E. Belcher Stereotyped and specific gene expression programs in human innate immune responses to bacteria Proc Natl Acad Sci USA 99 2002 972 977
28. P. Cohen, M. Bouaboula, M. Bellis, V. Baron, O. Jbiol, and C. Poinot-Chazel Monitoring cellular responses to Listeria monocytogenes with oligonucleotide arrays J Biol Chem 275 2000 11181 11190
29. J.E. Comer, C.L. Galindo, A.K. Chopra, and J.W. Peterson GeneChip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis Infect Immun 73 2005 1879 1885
30. R.L. McCaffrey, P. Fawcett, M. O'Riordan, K.D. Lee, E.A. Havell, and P.O. Brown A specific gene expression program triggered by Gram-positive bacteria in the cytosol Proc Natl Acad Sci USA 101 2004 11386 11391
31. C.B. Bigger, B. Guerra, K.M. Brasky, G. Hubbard, M.R. Beard, and B.A. Luxon Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees J Virol 78 2004 13779 13792
32. R.A. Irizarry, B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, and U. Scherf Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 2003 249 264
33. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation exposure Proc Natl Acad Sci USA 98 2001 5116 5121
34. F.C. Belton, H.M. Darlow, and D.W. Henderson The use of anthrax antigen to immunise man and monkey Lancet 271 1956 476 479
35. D.W. Henderson, S. Peacock, and F.C. Belton Observations on the prophylaxis of experimental pulmonary anthrax in the monkey J Hyg 54 1956 28 36
36. G.G. Wright, T.W. Green, and R.G. Kanode Jr. Studies on immunity in anthrax. V. Immunizing activity of alum-precipitated protective antigen J Immunol 73 1954 387 391
37. L.C. Iacono-Connors, S.L. Welkos, B.E. Ivins, and J.M. Dalrymple Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals Infect Immun 59 1991 1961 1965
38. B.E. Ivins, P.F. Fellows, M.L.M. Pitt, J.E. Estep, L. Welkos, and P.L. Worsham Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys Salisbury Med Bull 87 1996 125 126
39. P.R. Pittman, G. Kim-Ahn, D.Y. Pifat, K. Coonan, P. Gibbs, and S. Little Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans Vaccine 20 2002 1412 1420
40. C.P. Quinn, P.M. Dull, V. Semenova, H. Li, S. Crotty, and T.H. Taylor Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax J Infect Dis 190 2004 1228 1236
41. R. Sawada-Hirai, I. Jiang, F. Wang, S.M. Sun, R. Nedellec, and P. Ruther Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed J Immune Based Ther Vaccines 2 2004 5
42. S. Welkos, S. Little, A. Friedlander, D. Fritz, and P. Fellows The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores Microbiology 147 2001 1677 1685
43. M. Hallman, M. Ramet, and R.A. Ezekowitz Toll-like receptors as sensors of pathogens Pediatr Res 50 2001 315 321
44. S. Janssens, and R. Beyaert Role of Toll-like receptors in pathogen recognition Clin Microbiol Rev 16 2003 637 646
45. D. Werling, and T.W. Jungi TOLL-like receptors linking innate and adaptive immune response Vet Immunol Immunopathol 91 2003 1 12
46. R. Dziarski, Q. Wang, K. Miyake, C.J. Kirschning, and D. Gupta MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components J Immunol 166 2001 1938 1944
47. J.M. Park, V.H. Ng, S. Maeda, R.F. Rest, and M. Karin Anthrolysin O and other Gram-positive cytolysins are toll-like receptor 4 agonists J Exp Med 200 2004 1647 1655
48. E.N. Hatada, D. Krappmann, and C. Scheidereit NF-κB and the innate immune response Curr Opin Immunol 12 2000 52 58
49. I.M. Verma, and J. Stevenson IκB kinase: beginning, not the end Proc Natl Acad Sci USA 94 1997 11758 11760
50. A. LeBon, and D.F. Tough Links between innate and adaptive immunity via type I interferon Curr Opin Immunol 14 2002 432 436
51. K.W. Schjetne, K.M. Thompson, N. Nilsen, T.H. Flo, B. Fleckenstein, and J.G. Iversen Cutting edge - link between innate and adaptive immunity - Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target J Immunol 171 2003 32 36
52. R. Shtrichman, and C.E. Samuel The role of gamma interferon in antimicrobial immunity Curr Opin Microbiol 4 2001 251 259
53. S.H. Rhee, B.W. Jones, V. Toshchakov, S.N. Vogel, and M.J. Fenton Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages J Biol Chem 278 2003 22506 22512
54. S. Uddin, A. Sassano, D.K. Deb, A. Verma, B. Majchrzak, and A. Rahman Protein kinase C-δ (PKC-δ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727 J Biol Chem 277 2002 14408 14416
55. J.A. Gold, Y. Hoshino, S. Hoshino, M.B. Jones, and M.D. Weiden Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis Infect Immun 72 2004 1291 1297
56. J.A. Musson, N. Walker, H. Flick-Smith, E.D. Williamson, and J.H. Robinson Differential processing of CD4 T-cell epitopes from the protective antigen of Bacillus anthracis J Biol Chem 278 2003 52425 52431
57. K. Honey, and A.Y. Rudensky Lysosomal cysteine proteases regulate antigen presentation Nat Rev Immunol 3 2003 472 482
58. T. Nakagawa, W. Roth, P. Wong, A. Nelson, A. Farr, and J. Deussing Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus Science 280 1998 450 453
59. J.A. Villadangos, R.J. Riese, C. Peters, H.A. Chapman, and H.L. Ploegh Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism J Exp Med 186 1997 549 560
60. F. Ossendorp, N. Fu, M. Camps, F. Granucci, S.J. Gobin, and P.J. van den Elsen Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells J Immunol 174 2005 7815 7822
61. D.S. Allan, A.J. McMichael, and V.M. Brand The ILT family of leukocyte receptors Immunobiology 202 2000 34 41
62. R.H. McIntire, and J.S. Hunt Antigen presenting cells and HLA-G - a review Placenta 26 Suppl. A 2005 S104 S109
63. M. Shiroishi, K. Tsumoto, K. Amano, Y. Shirakihara, M. Colonna, and V.M. Braud Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G Proc Natl Acad Sci USA 100 2003 8856 8861